Amplitude Therapeutics has entered a research collaboration with Eli Lilly to develop trans-amplifying RNA vaccines for infectious diseases with high unmet need.
#Biotech #HealthInnovation #Biotechnology #Vaccines
Amplitude Therapeutics has entered a research collaboration with Eli Lilly to develop trans-amplifying RNA vaccines for infectious diseases with high unmet need. #Biotech #HealthInnovation #Biotechnology #Vaccines
0 vue
Publié le 25/08/2026 05:25
Amplitude Therapeutics has entered a research collaboration with Eli Lilly to develop trans-amplifying RNA vaccines for infectious diseases with high unmet need.
#Biotech #HealthInnovation #Biotechnology #Vaccines
0 commentaire
?